Financials data is unavailable for this security.
View more
Year on year Diaceutics PLC grew revenues 39.88% from 13.94m to 19.50m while net income improved 29.06% from 561.00k to 724.00k.
Gross margin | 92.82% |
---|---|
Net profit margin | 0.03% |
Operating margin | -2.41% |
Return on assets | 0.01% |
---|---|
Return on equity | 0.01% |
Return on investment | 0.01% |
More ▼
Cash flow in GBPView more
In 2022, Diaceutics PLC did not generate a significant amount of cash. However, the company earned 5.10m from its operations for a Cash Flow Margin of 26.13%. In addition the company used 4.76m on investing activities and also paid 191.00k in financing cash flows.
Cash flow per share | 0.0454 |
---|---|
Price/Cash flow per share | 24.78 |
Book value per share | 0.4861 |
---|---|
Tangible book value per share | 0.2958 |
More ▼
Balance sheet in GBPView more
Current ratio | 7.99 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0307 |
---|---|
Total debt/total capital | 0.0298 |
More ▼
Growth rates in GBP
Year on year, growth in earnings per share excluding extraordinary items increased 27.42%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years) | -2.47 |
---|---|
EPS (TTM) vs TTM 1 year ago | -149.24 |